当前位置:APASL-en-亚太肝脏研究协会年会 >> 正文
[APASL2013]Beyond Beta-Blockers in Portal Hypertension--interview with Dr.Shiv Kumar Sarin
—— 作者:S.K.Sarin 时间:2013-06-09
阅读数:
633
简介:In patients with cirrhosis, there is an increased resistance (to vasoactive drugs) and in order to overcome resistance, blood flow must increase. When this happens, the connections develop.
请登录后查看详细内容
标签:
专家访谈
专家访谈
门脉高压症
发表评论
全部评论